Curiox Biosystems Co., Ltd (KOSDAQ:445680)
South Korea
· Delayed Price · Currency is KRW 16,920
+410 (2.48%)
Last updated: Mar 25, 2025
Curiox Biosystems Revenue
In the year 2024, Curiox Biosystems had annual revenue of 4.59B KRW, down -32.41%. Curiox Biosystems had revenue of 955.96M in the quarter ending December 31, 2024, a decrease of -59.06%.
Revenue
4.59B
Revenue Growth
-32.41%
P/S Ratio
54.09
Revenue / Employee
n/a
Employees
n/a
Market Cap
248.80B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 4.59B | -2.20B | -32.41% |
| Dec 31, 2023 | 6.79B | -449.07M | -6.21% |
| Dec 31, 2022 | 7.24B | 1.71B | 31.04% |
| Dec 31, 2021 | 5.52B | 1.14B | 25.97% |
| Dec 31, 2020 | 4.38B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Electronics | 300.87T |
| SK hynix | 66.19T |
| LG Energy Solution | 25.62T |
| Samsung Biologics | 4,547.32B |
| Hyundai Motor Company | 175.23T |
| Celltrion | 3,557.30B |
| Kia Corporation | 107.45T |
| KB Financial Group | 15.01T |